Showing posts with label Bharat Bijlee. Show all posts
Showing posts with label Bharat Bijlee. Show all posts

17 May 2011

Bharat Bijlee Ltd Negative surprise from transformers ::Emkay

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Bharat Bijlee Ltd
Negative surprise from transformers


ACCUMULATE

CMP: Rs998                                        Target Price: Rs1,110

n     Q4 APAT of Rs46mn (down 73% yoy) is a negative surprise - led by rev. (Rs2.1bn vs est Rs2.8bn) & EBITDA margins (3.7% vs est 12.7%). PAT helped by part sale of Siemens investment
n     Transformers yet again surprised negatively- FY11P EBITDA margins (8.5%) lower by 260bps - though first 3 qtrs were ok. With ambiguity on margins in 12E/13E - we build in 8.5%
n     However, we continue to believe that motors business with 40% growth in FY11P with EBITDA margins (12.8%) improvement of 170bps is likely to shelter transformers
n     Reduce FY12E EPS by 35% & introduce FY13E EPS Rs89.2/share. At 3.8x FY13E EV/EBITDA (adj. for siemens stake at 30% discount), valuations at 10% disc peers. Given ambiguity on margins, lower the rating to Accumulate

26 April 2011

Bharat Bijlee BUY; Target- 1350 • Improving industry outlook :: Anand Rathi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Bharat Bijlee BUY -Target- 1350
Investment Rationale
• Improving industry outlook augurs well for the
bounceback
• Siemens India investment at significant value
• Any disinvestments of holdings unlock value for the
company
• Consistent dividend paying company and a bonus
candidate
• Expansion plans

25 January 2011

Buy -Bharat Bijlee Q3FY11 Result Update; In line; Target: Rs 1,350: Emkay

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Bharat Bijlee Ltd
In line; Reiterate Buy


BUY

CMP: Rs 1,088                                       Target Price: Rs 1,350

n     PAT grows by 92% yoy to Rs142mn (our expectations -Rs137mn) - driven by 28% revenue growth (mainly volume growth) and increase in EBITDA margins to 11.8% (+320bps)  
n     9mFY11 EPS stands at Rs62.2/Share (up 47% yoy), maintain earnings of Rs96.1 and Rs116.4 in FY11E and FY12E with upward bias going into Q4FY11E  
n     Valuations (3xFY12E EBITDA and 5.8xFY12E earnings) not pricing in value of inv. in Siemens (at 40% discount to CMP of Siemens, the value is Rs265/Share or 28% of BBL’s CMP);
n     Top pick in transformers pack; Reiterate Buy

Buy Bharat Bijlee: Target Price (Rs.) 1225; Upside 34% : Greshma

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Bharat Bijlee Ltd BUY
Horizon 12 months
Target Price (Rs.) 1225
Upside 34%


Investment Rationale
 Numbers to continue the uptrend
Company’s sales registered a growth of 22% in PAT to ` 150.7 mn yoy and the sales grew by 10% to ` 2025.5 mn on yoy basis. The numbers were fueled by the volumes growth of 20% in motors and better margins in transformer segment. We expect the company to post positive numbers in FY11 due to lower base effect.
 Market Value of Equity Investments `386 per share and value of liquid investments held at and `90 per share
BBL, which recently holds substantial part of its investments in Siemens and HDFC are now trading at magnificent premium over its cost of acquisition. The value of investments at current market prices after discounting fairly by 50% and adding holdings in liquid investments sums up to ` 283 per share.
 End-to end presence in power equipments
The company operates in the manufacturing of transmission& distribution transformers and also motors and elevators. The major focus of the company remains on the growing demand from the transformer segment, growing volumes in motors helps it to hedge the falling realizations.

29 October 2010

Bharat Bijlee Ltd Improvement accelerates, upgrade to Buy :: Emkay

Bookmark and Share
Visit http://indiaer.blogspot.com/ for complete details �� ��


Bharat Bijlee Ltd
Improvement accelerates, upgrade to Buy


BUY

CMP: Rs 1,088                                       Target Price: Rs 1,350

n     PAT grow by 22% yoy and 160% qoq to Rs151mn (our expectations – Rs129mn) - driven by increase in EBITDA margins to 13.8%  
n     Higher EBITDA margins driven by both transformers (better margins on low base) and motors (volumes growth of 20% drive operational leverage)
n     Revenue growth at 8%, below expectations of 13% growth 
n     Maintain earnings; Valuations (EV) cheap on absolute basis at 3.9x FY12E EBITDA as well as relative basis at 20% discount to peers; Top pick in transformers pack; Upgrade to Buy

28 October 2010

Research Views from Emkay; 28 October, 2010

Bookmark and Share
Visit http://indiaer.blogspot.com/ for complete details �� ��


n        Research Views
Bank of Baroda Q2FY11 result estimates
Net interest income likely to be strong, led by robust advance growth. However higher employee expense on account of gratuity, pension liabilities and investment depreciation will result in moderate growth at the operating level. Behaviour of restructured asset- key thing to watch out.
Punjab National Bank Q2FY11 result estimates
We expect PNB’s NII to grow by 27.5%yoy driven by a healthy growth in advances albeit NIM’s to contract by 15bps sequentially on account of higher cost of funds. Key thing to watch out will be behaviour of the restructured asset which was on higher side for PNB amongst PSBs. Strong growth in income to help provide higher for NPAs too.
Andhra Bank Q2FY11 result estimates
Andhra bank is expected to report strong growth in NII led by healthy advance growth and stable NIM’s, however lower trading gains as compare to last year will moderate Net income growth. The bank could see significant recoveries and upgradations during the quarter.
Elecon Engineering Q2FY11 Results – First Cut Analysis
Marginally above estimates
Elecon Engineering reported good all-round performance in Q2FY11 – marginally above estimates.
n    Revenues grew 10.1% yoy to Rs2809 mn, marginally ahead estimates – led by strong growth in Transmission Equipment (TE) division. TE division grew by 32.7% yoy to Rs1251 mn (ahead estimates) while MHE division decreased 3% yoy to Rs1610 mn (in line with estimates).
n    EBITDA growth was healthy at 8.4% yoy to Rs400 mn and EBITDA margins declined marginally by 20 bps yoy to 14.2% - in line with estimates.
n    Led by good operational performance as well as 20% decline in interest costs, adjusted net profits increased by 31.9% yoy to Rs142 mn – marginally above estimates.
n    Order inflows during the quarter were Rs2.1 bn – down 65% qoq and up 7% yoy. Order Book declined marginally sequentially to Rs15.0 bn (including Rs3.23 bn order from Bramhani Steel – currently on hold)
At CMP, the stock is trading at 14.2X FY11E and 10.4X FY12E earnings of Rs6.9 and Rs9.4 per share respectively. We have a BUY rating on the stock.
Thermax Standalone Q2FY11 Results – First Cut Analysis
Stellar performance yet again – above estimates
Led by uptick in industrial activity, Thermax posted yet another quarter of strong performance.
n    Revenues grew by a robust 60.4% yoy to Rs10.9 bn, above estimates - led by strong growth in both segments. Environment segment continued to witness strong traction in revenues – up 50.6% yoy to Rs2.5 bn, above estimates. Led by a growing order backlog, Energy segment grew by 70.9% yoy to Rs8.9 bn, above our estimates.
n    Led by strong revenues and stable EBITDA margins at 11.8%, EBITDA growth was robust at 62.3% yoy to Rs1286 mn – above estimates. Energy segment EBIT margins declined 160 bps yoy to 10.2% while Environment EBIT margins dropped by 40 bps yoy to 12.4%.
n    Led by strong operational performance, net profits increased by 65.4% yoy to Rs895 mn, above estimates.
n    At the consolidated level, revenues increased 61% yoy to Rs11.65 bn and net profits grew by 57% yoy to Rs914 mn, above estimates. The subsidiaries posted a profit of Rs19 mn – below estimates.
We have a positive bias on Thermax in view of uptick in industrial capex, robust order backlog and inflows, earnings visibility for next 2 years. Currently, we have earnings of Rs31.8 and Rs39.5 per share for FY11E and FY12E respectively. We have a BUY rating.
Bharat Bijlee Q2FY11 Results First Cut
Improvement accelerates, higher than expectations
n    PAT grow by 22% yoy and 160% qoq to Rs151mn (our expectations – Rs129mn); significant improvement driven by improvement in EBITDA margins to 13.8% (up 140bps yoy) due to low base. 
n    Revenue growth at 8%, below expectations of 13% growth 
n    Earnings for the quarter stood at Rs26.8/Share.
n    H1FY11 EPS stands at Rs37.1/Share (up 27% yoy)
n    Likely to maintain earnings of Rs96.1 and Rs116.4 in Fy11E and FY12E with upward bias going into Q3FY11. H2FY11 implied number stand at Rs59/share (growth of 35% yoy).
n    At CMP of Rs1087, the Stock is trading at 7.2xFY12E earnings & 1.6xFY12E Book Value (ex Siemens investment at 50% discount to CMP). The valuations are at 20% discount to peers at 9x. We currently have an accumulate rating on the stock with a target of Rs1350/Share. We will come out with a detailed update post discussion with mgmt….
n        Research Update Included
Patni Computers Q3CY10 Result Update; In line quarter, Disappointing Guidance for Q4CY10; Not Rated
n    Rev at US$ 178.8 mn, marginally ahead of est. Mgns at 18.9%, were down by ~130 bps QoQ  impacted by strong hiring (net adds of 1,663, +11% QoQ), impact of consolidation of CHCS
n    Profits at Rs 1.3 bn ahead of est. driven by higher than expected forex gains. See margin pangs continuing driven by supply side pressures( attrition at near peak levels)
n    Despite strong hiring, co’s Dec’10 rev guidance is muted. Patni’s rev growth continues to be anemic with strong margin defence until now getting threatened as expected by us
n    Tweak CY11E EPS down by ~5.7% to Rs 35.3 driven primarily by lower margin assumptions (partly on a/c of higher currency reset). At Rs 465, Patni trades at 13.1x/11.7x CY11E/12E EPS
United Phosphorus Q2FY11 Result Update; Results below estimates; Buy; Target: Rs 230
n    Q2FY11 results were marginally lower than estimates due to weak margins with RPAT of Rs 1.15 bn, +12%yoy
n    Implied H2FY11 revenue and EBITDA growth of 33% and 52% on higher side – may risk FY11 management guidance
n    We have adjusted downward our FY11 revenue, EBITDA and APAT estimates by 5.8%, 2.9% and 1.5%, respectively
n    Maintain BUY recommendation with target price of Rs 230 based on 12x FY12 estimates. Growing profit contribution from India is likely to drive valuations going forward
Ultratech Cement Q2FY11 Result Update; Numbers Disappoint. Maintain REDUCE; Target: Rs1040
n    PAT at Rs1.16 bn (-79.2% qoq) – below estimates led by lower realizations & higher P&F & staff costs. Revenues decline 19.4% qoq-volumes down 12.4%, realisations down 8%
n    Lower realizations and cost pressure dragged EBIDTA down by 59% qoq. EBITDA/t at Rs448 down 53.4% qoq. Downgrade FY11 earnings by 16.2% (EPS Rs54.8)
n    With recent cement prices hikes, expect the worst phase of profitability to be over for UTCL
n    Upgrade target to Rs1040 (valuing UTCL at EV/EBIDTA of 8X EV/Ton of USD130. However rich valuations at PER of 16.6X & EV/ton of USD135 leaves little upside. Maintain REDUCE
NTPC Q2FY11 Result Update; MAT grossing to hit ROE by 4%; Downgrade to Hold; Target Price: Rs 190
n    Results disappoint (APAT down 2%) due to (1) grossing up ROE at MAT, (2) Kahalgaon/Farakka continue to report lower PAF (70%) on fuel constraints & (3) lower interest income
n    Changed the grossing up to MAT rate frm earlier full tax rate; to hit profits by Rs10bn or 4% of core ROE from 28% to 24%
n    Reduce earnings by 11-13% in FY11E/12E
n    Valuations at 2.3xFY12E Book value, not attractive on core ROE of 24% (Earlier 28%); Lower target price to Rs190/Share; Downgrade to ‘Hold’
DB Corp Q2FY11 Result Update; Results miss est., Cut rating to HOLD; Target: Rs284
n    Q2FY11 PAT grew by 20.8% yoy to Rs550mn, below our estimate of Rs770mn impacted by sharp rise in opex towards new launches
n    Advertisement revenues grew by 16% yoy to Rs3bn equally led by volume and price growth
n    Cut EPS estimate by 10% /2% to Rs13.6 /14.6 for FY11E/12E due to higher than expected opex on new launches
n    Downgrade rating from ACCUMULATE to HOLD with target price Rs284
Union Bank of India Q2FY11 Result Update; Provisioning hits bottom-line; downgrade to HOLD; Target: Rs400
n    UBI’s Q2FY11 net profit at Rs3.0bn (-40%yoy), significantly below expectation led by higher provisioning and opex
n    The NII at 15.4bn inline with expectation, led by 30bps expansion in NIMs, albeit advances remaining flat qoq
n    The slippages during the quarter were higher at Rs11.3bn (3.6% annualised) including Rs4.2bn from agriculture NPAs, Rs760mn from restructured pool & Rs2.2bn from one big a/c 
n    Valuations expensive at 1.7x FY12E looking at sharp slippages and provision requirements. Downgrade to HOLD rating with TP of Rs400
Asian Paints Q2FY11 Result Update; Volume Allude, Maintain HOLD; Target Price: Rs 2,510
n    Asian Paints (APL) reported mixed performance – revenue growth at 5% yoy missed expectation and APAT growth at 4.4% yoy meets expectation
n    Volume growth alluded in the quarter- on back of high volume growth in Q1FY11 leading to pipeline filling and higher dealer inventory
n    Maintain earnings for FY11E (Rs92.2/Share) and FY12E  (Rs104.6/Share) – Maintain ‘HOLD’ rating with target price of Rs2510/Share
Marico Q2FY11 Result Update; Price Hike Initiated, Maintain HOLD; Target: Rs 128
n    Marico’s Q2FY11 performance meets expectation - revenue growth of 12.5% yoy to Rs7.8 bn and APAT growth of 14.8% yoy to Rs715 mn
n    Implemented price hike to offset material price inflation - 13% in ‘Parachute’ and ‘10%’ in ‘Saffola’ rice bran oil
n    Satisfactory volume growth at 15% yoy - ‘Parachute’ grew by 10%, ‘Saffola’ grew by 18% and ‘Hair oil’ grew by 27%
n    Maintain earnings estimates of Rs4.9/Share and Rs5.8/Share for FY11E and FY12E – Maintain ‘HOLD’ rating with price target of Rs128/Share
Voltas Q2FY11 Result Update; H2FY11 Promise; Retain BUY; Target Price: Rs 275
n    Results marginally below estimates with (1) 3% yoy decline in revenues to Rs10.7 bn (2) 140 bps yoy drop in EBITDA margins and (3) 17% yoy decline in PAT to Rs746 mn
n    EMP division performance negatively impacted due to slower execution on international orders & one-off expenditure
n    Order inflows up 76% yoy to Rs8.5 bn – YTD secured 44% of FY11E target order flows. Order book at Rs49.7 bn – equivalent to 1.4X standalone FY10 revenues
n    Maintain earnings estimates and Maintain ‘BUY’ with target price of Rs275/Share
TRF Q2FY11 Result Update; Negative Surprise Galore, Downgrade to Accumulate; Target Price: Rs 754
n    Q2FY11 results is loaded with negative surprise due to (1) one-offs provision of Rs0.3 bn and (2) dismal revenue booking in Projects division
n    Fires another salvo – revised Ebidta margins guidance from 10% to 7% - for reasons less understood and unexplainable
n    Downgrade in earning estimates for FY11E (down 43% to Rs36.1/Share) and FY12E (down 34% to Rs58.4/Share)
n    20% drop in market capitalization partly discounts earnings revision -  Downgrade from ‘BUY’ to ‘ACCUMULATE’ with revised target price of Rs754/Share

26 October 2010

Emkay: Research Views: Oct 26th 2010

Bookmark and Share Visit http://indiaer.blogspot.com/ for complete details 􀂄 􀂄


n        Research Views
Voltas Q2FY11E Result Estimates
Post strong performance in Q1FY11, expect Voltas to report subdued performance during the quarter. This is primarily attributed to low order inflow in 9MFY10.
n    Expect revenue growth to be lower at 9% YoY to Rs12 bn – due to mere 7% YoY growth in EMP division. EPS and UCP division growth to be healthy at 17% and 20% YoY respectively.
n    Expect EBITDA to decline by 10% YoY to Rs1.1 bn due to 200 bps YoY drop in EBITDA margins to 9.5%.
n    APAT growth to be muted at 6% YoY – primarily due to lower tax incidence.
Management outlook on international order inflows will be tracked closely.
TRF Q2FY11E Result Estimates
Standalone estimates:
n    We expect TRF to report healthy performance in Q2FY11E led by robust order backlog at Rs20 bn.
n    Expect revenues to grow by 23% YoY to Rs1.6 bn – led by Products (+20% yoy to Rs1258 mn) and Projects (+12% yoy to Rs580 mn).
n    Expect EBITDA growth at 20% YoY to Rs193 mn with 30 bps YoY drop in margins to 11.8%.
n    Expect APAT growth at 22% YoY to Rs108 mn.
Consolidated estimates
n    We expect TRF’s auto components business to continue to report strong on yoy basis – but flat growth on qoq basis during the quarter.
n    We expect revenues of Rs2.6 bn (+39% YoY), EBITDA at Rs214 mn (+45% YoY) and APAT at Rs97 mn(-3% YoY).
We will keenly await Management guidance & outlook on automotive business – The management expected to share guidance on the automotive components business for the first time with investors.
Elecon acquires business in gears & gearboxes for EV of Rs1.3 bn
Elecon Engineering (EEL) has acquired certain Europe based businesses for gears and gearboxes from David Brown Gear Systems for a total enterprise value of Rs1.3 bn (GBP 18.4 mn). EEL has made the acquisitions through its 100% subsidiary (step-down) Elecon USA Transmission Ltd. The details of the acquisitions are as follows:
We await further details on the acquisition to judge the impact on revenues and earnings. EEL has debt of Rs5.2 bn (as on Mar’10) with a DER of 1.5X.
At CMP the stock is trading at 13.8X FY11E and 10.1X FY12E earnings of Rs6.9 and Rs9.4 per share respectively. We have a BUY rating on the stock.
Bharat Bijlee Q2FY11E Result Estimates (Results on 27th Oct)
Healthy volume growth across segments - transformers, projects and motors to drive revenue growth of 13% yoy. The EBITDA margins are expected to remain flat yoy at 12.2% (20bps decline). PAT is expected to grow 4% YoY to Rs129mn (up 121% qoq). Key things to watch - (1) performance of motors business, (2) order inflows and realizations trend in transformers, (3) pick up in projects business and (4) overall margins.  
United Phosphorus (Conso) Q2FY11 Results Expectations - Net Sales Rs 13.1 bn, APAT Rs 1.5 bn
United Phosphorus is expected to declare their results today i.e. October 26th, 2010.
We estimate global recovery in demand and improved weather conditions to reflect by way of 13% YoY growth in revenues to Rs 13.1 bn. We expect India and North America to grow by 20% each followed by 15% growth in Rest of the World while Europe is likely to remain weak with 5% decline in revenues. EBITDA margins are expected to expand by 250 bps YoY to 19.5% leading to a 30% growth in EBITDA to Rs 2.6 bn. We estimate APAT at Rs 1.5 bn, +12% YoY with an EPS of Rs 3.4. Previous year PAT is adjusted for forex loss of Rs 300 mn loss. The company reported profit of the Rs 1 bn last year.
Deepak Fertilisers Q2FY11 Results Expectation : Net Sales Rs 3.9 bn, PAT Rs 469 mn
Deepak Fertilisers is expected to report their Q2FY11 results today i.e. October 26th, 2010.
Higher sale volumes for complex fertilisers are likely to result in 16% YoY increase in fertiliser revenues to Rs 1.7 bn. Chemical revenues are expected to increase by 7% to Rs 2.24 bn. Consequently, overall revenues are expected to increase by 10% YoY to Rs 3.9 bn. We estimate fertiliser and chemical segment margins to increase by 300 bps each to 8% and 30% respectively resulting in 250 bps expansion in overall margins to 22.8% and a consequent 23% increase in EBITDA to Rs 886 mn. We estimate APAT of Rs 469 mn, +29% YoY resulting in AEPS of Rs 5.3 as against Rs 4.1 in Q2FY10.
United Bank Of India Q2FY11 results in line with expectations; slippages surpirse positively
n    UNTDB’s Q2FY11 earnings were in line with our estimates with NII at Rs5.3bn and PAT at Rs1.1bn
n    Other income growth strong at 26%qoq to Rs1.5bn; The bank has used robust other income for provisions/write offs.
n    The slippages have surprised positively at Rs2bn (Rs2.5bn in Q1FY11, our exp – Rs2.5bn). The NPAs have remained largely stable during the quarter. PCR at 50%, 71.7% as per RBI norm
n    Valuations at 1.7x FY11E/1.3x FY12E ABV. We will review our rating and TP. However, retain our positive bias
NII grew inline with estimates…
UNTDB NII for Q2FY11 grew by 48% yoy to Rs5.3bn inline with expectations. The NII growth was driven by 13% yoy (3.7% qoq) growth in advances and stable NIMs at 2.7%.
Titan Q210 Performance Is Ahead Of Estimates...
n    Revenue growth  of 33.9% yoy to Rs15.4 bn - Ahead Of Estimates
n    Ebidta growth at 60.5% yoy to Rs1.7 bn - Ahead Of Estimates
n    APAT growth of 64.6% yoy to Rs1.3 bn - Ahead Of Estimates
n    At Segment Level
n    Watches grew by 19.7% yoy to Rs3.5 bn and Ebit grew by 169% yoy to Rs763 mn
n    Jewellery grew by 36.7% yoy to Rs11.2 bn and Ebit grew by 365% yoy to Rs998 mn 
n    Other grew by 80.6% yoy to Rs560 mn and Ebit loss reduced to Rs47 mn
n    Current earnings estimates at Rs93/Share and Rs121/Share for FY11E and FY12E respectively. Probability of 10% earnings upgrade to FY11E and FY12E earnings.
n        Research Update Included
Dr Reddy's Lab Q2FY11 Result Update; Higher traction from FY12 onwards; Accumulate; Target: Rs1763
n    Muted performance in US and decline in PSAI segment impacted top line performance in Q2FY11; significant ramp-up in niche products to drive sales from H2FY11 onwards
n    Branded formulation markets of India and CIS reported strong traction
n    361 bps YoY expansion in EBITDA margins at 18.6% and 33% growth in recurring PAT led by 592bps expansion in gross margins and lower tax provisioning
n    Revise base business earnings for FY11E, FY12E and introduce NPV for limited competition opportunities; Maintain Accumulate with a revised price target of Rs1763
Emkaynomics Economy Update; October 08, 2010; Fortnightly round up of key banking and economic indicators
n    The growth in the non food credit has moved upwards to 20.1% for the week ended Oct. 8, 2010 and deposit mobilization inched up to 15.1%
n    The CD ratio has moved marginally downwards to 72.4% for the week ended Oct. 8, 2010
n    Money supply growth has increased to 15.9% and the money multiplier has grown to 5.12
n    Call money rates as on Oct. 25, 2010 have risen by 86bps from last fortnight to 6.4%, with a brief move to 6.66% last week
n    The spread between call money and reverse repo rates has widened as on Oct. 25, 2010 and stands at 140 bps
n    Excess liquidity is absent in the system and stood at `-18.5 bn.  The repo balances stood at ~ `236 bn. and reverse repo at ~ `11 bn. for the week ended Oct. 8, 2010
n    The spread between the long and short end OIS has eased and stand at 30bps as opposed to 58 bps last fortnight
Bajaj Auto Q2FY11 Result Update; Volume upgrade continues, raise TP to Rs 1,710; Accumulate
n    EBIDTA at Rs 9.1bn (5% above est.) due to higher than expected topline (Rs 43.4bn vs est. Rs 41.3bn). APAT at Rs 6.9bn (6.5% above est.)
n    FY11 export target raised to 1.15mn units (our est. 1.2mn units). 70% of FY12 current exports est. are hedged. Price hike in Oct’10 only for dom. market
n    Upgrade FY11E/FY12E vol. by 2.1% /3.2% to 3.9mn/ 4.7mn units. Upgrade FY11E/FY12E EPS by 4.0%/5.1% to Rs 87.1/Rs 110.3 . 20%+ margins are sustainable subject to product mix
n    Upgrade TP by 4.9% to Rs 1,710 (15.5x FY12 EPS). Maintain ACCUMULATE rating.
Ashok Leyland Q2FY11 Result Update; Mixed Bag, Maintain HOLD; Target: Rs 76
n    EBIDTA at Rs 3.1bn was in line with our est. despite lower than expected net sales. Margins at 11.3% were above our est. of 10.8%. APAT at Rs 1.7bn marginally below est.
n    Hike prices by 3%/6% for BSII/BSIII vehicles over the 4% hike taken in H1FY11. Currently, it has inventory of ~9000 units
n    Raises FY11 volume guidance to 95000 units (our est. is 92692 units). Upgrade FY11E EPS by 4.2% to Rs 5.2, retain FY12E EPS at Rs 6.4.
n    Retain our TP of Rs 76 and our HOLD rating. M&HCV demand momentum to peak out, expect concerns with volume growth for FY12 from 3Q/4Q FY11
TVS Motor Q2FY11 Result Update; In line, lower rating to REDUCE; Target: Rs 72
n    EBIDTA margin at 6.7 below est. of 6.9%, despite higher net sales (Rs 16.2 bn against est. of Rs15.8bn) due to higher staff cost and other exp. APAT at Rs 549mn against est. of 526mn.
n    Scooter/Mopeds/3-Wheelers continue to drive volumes, motorcycle sales continue to disappoint. Export traction to remain strong, expect average run rate of ~20k unit’s pm.
n    Upgrade FY11E/FY12E volumes by 6.4%/8.5% to 2.0/2.3 units due to higher scooters/mopeds/exports sales. Upgrade FY11E/FY12E standalone EPS by 4.5%/7.4% to Rs 4.1/Rs6.0
n    Upgrade TP to Rs 72 (up 7.5%) - 12x FY12 standalone EPS. Downgrade rating to REDUCE
Torrent Pharma Q2FY11 Result Update; On Track; Maintain Buy; Target: Rs650
n    Revenue growth is above our estimates on account of 22% increase in domestic formulations and higher than expected growth in the international business
n    EBITDA margins declined (as estimated) on account of 468bps contraction in gross margins, higher employee cost and other expenses
n    Higher than expected rise in depreciation and interest impacted PAT (Rs762mn vs. est. of Rs817mn)
n    Maintain earnings and Buy rating with a target price of Rs650
Hindustan Unilever Q2FY11 Result Update; No Catalysts, Downgrade to REDUCE; Target: Rs 275
n    HUL reported spectacular volume growth of 14% in Q211, back of 11% in Q111 and Q410
n    Q211 performance stood marginally ahead of expectation – revenue growth 9.7% yoy to Rs42.8 bn and APAT decline of 5.2% yoy to Rs5.2 bn
n    Q211 performance for key segments on expected lines, except personal products that recorded 330 bps yoy and 180 bps qoq reduction in EBIT margins
n    Absence of strong earnings upgrade catalysts and recent stock performance – downgrade HUL from ‘HOLD’ to ‘REDUCE’ with revised target price of Rs275/Share